<DOC>
	<DOC>NCT01116258</DOC>
	<brief_summary>The purpose of this study is to determine the safety, tolerability and blood levels of AZD5847 after daily oral dosing for 14 days.</brief_summary>
	<brief_title>A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days</brief_title>
	<detailed_description />
	<criteria>BMI between 1830 Use of drugs that inhibit or induce cytochrome P450 3A4 enzymes History of presence of gastrointestinal, hepatic or renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Safety</keyword>
</DOC>